Oracz G, Pertkiewicz J, Kierkus J, Dadalski M, Socha J, Ryzko J. Efficiency of pancreatic duct stenting therapy in children with chronic pancreatitis.
Gastrointest Endosc 2014;
80:1022-9. [PMID:
24852105 DOI:
10.1016/j.gie.2014.04.001]
[Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/12/2013] [Accepted: 04/01/2014] [Indexed: 02/07/2023]
Abstract
BACKGROUND
Chronic pancreatitis (CP) is a rare disease in childhood. Although ERCP is commonly performed in children, the effect of pancreatic duct stenting therapy in children with CP is unknown.
OBJECTIVE
To investigate the efficacy of pancreatic duct stenting in children with CP.
DESIGN
Retrospective analysis.
SETTING
National referral center.
PATIENTS
A total of 208 children with CP hospitalized between 1988 and 2012.
INTERVENTIONS
ERCP with pancreatic duct stenting.
MAIN OUTCOME MEASUREMENTS
Results of endoscopic therapy and number of pancreatitis episodes per year before and after treatment.
RESULTS
A total of 223 pancreatic duct stenting procedures were performed in 72 children. The median number of stent replacements was 3 (range 1-21). A statistically significant decrease in the number of pancreatitis episodes per year was observed: from 1.75 to 0.23 after endoscopic treatment (P < .05). Pancreatic duct stenting was performed more frequently in patients with hereditary pancreatitis (61.5%) and in children with CP and anatomic anomalies of the pancreatic duct (65%; P < .05).
LIMITATIONS
Retrospective analysis with the assessment of adverse events based on medical history.
CONCLUSION
Pancreatic duct stenting therapy is a safe and effective procedure in children with CP. This therapy should be recommended especially for children with hereditary pancreatitis and patients with anatomic anomalies of the pancreatic duct.
Collapse